Basics: short version, verdict first People Molecules Peptides Biomarkers Studies Stem Cells Editorial Methodology
Layer 1 · Decision
← All products
ProHealth Longevity

NMN Pro 1000

NAD+ booster · Capsule · 30 servings

Label snapshot

What the label says

What the product contains and what one serving costs, according to our catalog. Label amounts are not personal dose recommendations.

Precursor per serving
NMN 1,000 mg
Form
Capsule
List price (catalog, USD)
$79.00
Price per serving
$2.63List price divided by servings per container. A per-day cost only if the label serving is once daily.
Full label record: servings, testing, ingredients
Servings per container
30
Serving size (label)
1 g
Catalog monthly estimate
$79.00
Testing disclosure
Brand lists third-party testing and a public certificate of analysis (CoA)Status as recorded in the catalog from brand materials; not independently verified by NO1GEVITY.

Ingredients as listed

IngredientAmount per serving
NMN1,000 mg

What to check on the label

  • Which precursor is named. NMN and NR are different molecules and are not interchangeable milligram for milligram.
  • Whether the milligram figure is per capsule or per serving of several capsules. The catalog records per serving.
  • Whether a certificate of analysis (CoA) is published for the batch you buy. The catalog only records whether the brand lists one.
  • Added ingredients (resveratrol, TMG, quercetin) are listed with their own amounts below. Read them separately.

Amounts are per label serving as recorded in the catalog and are not a recommendation. Testing status reflects what the brand lists. Nothing here is medical advice.

Editorial score and research-dose calculations

These calculations describe our scoring method. They are not a recommended dose or proof of benefit from this product.

8.0/10
Overall score
#6 / 52 in NAD+ booster

Public lab certificate, tested by independent lab.

Read the evidence (3 studies)
Add to compareVisit brand site →
Watch outEU restricted1 ingredient restricted in the EU
  • NMN — Unauthorised Novel Food; EFSA positive safety opinion adopted 4 March 2026 at up to 300 mg/day (β-NMN, EffePharm dossier). Commission listing pending.
You can legally buy these outside the EU. Sale as a food supplement inside the EU requires a Novel Food authorisation these ingredients do not have.
Tier 4
Ingredient RCT (different dose)
The ingredient was tested in an RCT but at a different dose, or only in animals.
See the 3 supporting studies
  • Yi et al. 2023 (GeroScience) (NMN)In an 80-person, 60-day dose-dependent RCT, oral NMN (up to 900 mg/day) significantly raised blood NAD+ levels, was safe and well-tolerated, and improved six-minute walking distance versus placebo. Studied at 900 mg. This product: 1000 mg.
  • Uthever RCT 2022 (NMN)In 66 adults aged 40-65 over 60 days, NMN (300 mg/day) increased serum NAD+/NADH by 38% versus baseline and improved SF-36 quality-of-life scores compared to placebo. Studied at 300 mg. This product: 1000 mg.
  • Okabe et al. 2022 (Frontiers in Nutrition) (NMN)A 30-person, 12-week RCT found 250 mg/day oral NMN significantly increased whole-blood NAD+ levels with no adverse effects. Studied at 250 mg. This product: 1000 mg.
How we scored this product Show the full breakdown
Dose vs. studies (50%) Why 7.9 of 10. Primary ingredient is NMN (evidence grade B). It delivers 1000 mg, above the studied range of 250–900 mg. Above the range docks the score because nobody has tested that much. Read the rule → 7.9
Transparency (20%) Why 9.0 of 10. Earned points for public certificate of analysis and independent third-party testing and all doses disclosed. Read the rule → 9.0
Value (10%) Why 8.3 of 10. One day at the trial dose costs about $1.32. That is cheaper than average (142 of 313 by cost per effective day). Read the rule → 8.3
Formulation (10%) Why 5.0 of 10. No published absorption advantage or disadvantage on file. The default of 5 is not a criticism. Read the rule → 5.0 Default. No absorption data on file.
Safety (5%) Why 8.5 of 10. Baseline 5.0. Third-party testing adds 2.0. Public lab certificate adds 1.5. NSF, USP or Informed Choice certification adds 1.5. Active safety signal subtracts 3.0. Read the rule → 8.5
Community sentiment (5%) Why 9.3 of 10. Sentiment across 10 external review source(s) is mostly positive. Community is a signal about daily use, not proof of effect. Read the rule → 9.3
Composite How this 8.0 is built. 0.50 × 7.9 + 0.20 × 9.0 + 0.10 × 8.3 + 0.10 × 5.0 + 0.05 × 8.5 + 0.05 × 9.3 = 8.0 out of 10. Safety caps applied after. 8.0
8.0 composite
Dose vs. studies50%7.9
Transparency20%9.0
Value10%8.3
Formulation10%5.0
Safety5%8.5
Community5%9.3

Evidence gates dose: the evidence grade sets the ceiling, and the dose decides how much of that ceiling the product reaches. Value = inverse of price-per-trial-dose-day. Community = mean sentiment of external reviews. Safety caps applied after weighting.

This score is our editorial judgment, not a scientific standard. We combine published evidence, dose, price, transparency, and consumer signals into one composite: this is our method, not a peer-reviewed clinical rating. A higher score means a product does better on the factors we weight, not that it is medically proven to work.

Read the full method →

Editorial verdict

Quick verdict

8.0 / 10
Best for
Full trial dose, Public lab certificate
Avoid if
No major red flags
Full-dose status
Meets trial dose
Price/month
$79
COA status
Public
Biggest caveat
NMN (1000mg is 200% of the 500mg trial dose) is well above the trial dose. More is not always better.
Nearest alternatives
Catalog snapshot. Check linked sources for current price, label and batch-specific testing.
Price verification
Current price: $79.00
Last price check: Sep 01, 2026
Add to compareVisit brand site →
Layer 2 · Context

Our summary

ProHealth Longevity's NMN Pro 1000 delivers 1000 mg of Uthever-brand NMN per serving, four times the 250 mg dose used in the most-cited academic human trials (Yoshino et al. 2021, Igarashi et al. 2022, Morifuji et al. 2024), and roughly matches the top of the Effepharm-sponsored dose-ranging range (up to 900 mg) but has not itself been tested in a peer-reviewed trial at exactly 1000 mg or as this finished capsule. The strongest ingredient-level evidence comes from Effepharm's own Uthever trials (Huang et al. 2022; Yi et al. 2022), which show real NAD+ and quality-of-life improvements at lower doses but carry a manufacturer conflict of interest, placing this product at Tier 4 (ingredient RCT, different dose). A prior independent purity test found ProHealth's labeled NMN content accurate, a genuine positive signal in a category where many competing products have failed similar tests, but buyers should treat the vendor's 'decreased biological age by 12 years' and '100x absorption' marketing claims with real skepticism, as neither is fully supported by the cited science once examined closely.
In plain language

Why this scored this way

This ProHealth Longevity NMN Pro 1000 scores 8.0, making it a strong scorer. It delivers 1000mg of NMN, above the studied range of 250–900mg with grade B evidence (promising human data, not yet comprehensive). Transparency is a clear strength (score: 9.0), with third-party testing and a public lab certificate.

What drives the score up

  • Dose-evidence score of 7.9 shows decent alignment with trial doses.
  • Quality transparency of 9.0: tested by independent lab with a public lab certificate.
  • Community score of 9.3 with positive consumer feedback.
  • NMN is dosed at the full research level with grade B evidence (promising human data, not yet comprehensive).

What drags it down

  • NMN (1000mg is 200% of the 500mg trial dose) is well above the trial dose. More is not always better.

Why you'd choose it

  • You want a reasonably priced nad+ booster product.
  • You want NMN from a ProHealth Longevity product.
  • You prioritise tested by independent lab products with public lab certificates.

Why you might skip it

  • You want a standard dose of nmn (this product is well above it).
  • You want better value (this is $1.32/day with a value score of 8.3).
Question 1

Does the molecule work?

The science behind each active ingredient, independent of which brand sells it.

NMN

A NAD+ building block that has become the most-hyped longevity molecule.

5 landmark RCTs · US: FDA reversed exclusion 29 September 2025; NDIN 1247 and NDIN 1259 reinstated 2 December 2025; NDIN 1444 (β-NMN, Effepharm) response 28 January 2026. NMN is a dietary ingredient again; each marketer still needs NDIN coverage. · EU: Unauthorised Novel Food; EFSA positive safety opinion adopted 4 March 2026 at up to 300 mg/day (β-NMN, EffePharm dossier). Commission listing pending.
Question 2

Is this bottle good?

The specific product: dose, price, transparency, and what buyers report.

Dose vs research
400% of trial dose
Meets or exceeds the published effective dose
Cost at trial dose
$1.32/day at trial dose
What one effective daily dose actually costs
Transparency
9.0/10 · Public lab certificate (quality: not assessed)
Independent batch testing confirmed
Consumer signals
800 reviews across platforms · 4.7/5 · high confidence
Operational signal only, never used as clinical evidence
Question 3

What's the catch?

Safety flags, transparency gaps, dosing concerns, and recurring buyer complaints.

No major red flags
Public lab certificate, tested by independent lab, dose within range
No safety, transparency, or dose concerns detected at this time.
Plain English

What’s inside

The main ingredients of this product, in plain language.

NMN1000 mgEvidence B

A NAD+ building block that has become the most-hyped longevity molecule.

Read about NMN →
Layer 3 · Evidence vault

Product data & verification

Hard numbers and independently checked status. Expand each block for its source.

The numbers

Price
$79
per bottle · 30 servings
Dose vs. research
Above trial dose 400%
of published effective dose
$ / day at studied dose
$1.32
what one effective daily dose costs
$ / g active
$2.63
per gram of active substance
Independently checked

Data verification

COA status
Public
Evidence grade
B
Per-ingredient breakdown
BNMN

All product data is checked against original sources. Prices, doses, and testing status are updated when product pages change. Evidence grades are reviewed when new human RCTs are published. Read how we verify.

What's inside

Ingredient
Dose in this product
Trial dose
Evidence
NMN
A NAD+ building block that has become the most-hyped longevity molecule.
Yi et al. 2023 (GeroScience)Okabe et al. 2022 (Frontiers in Nutrition)Uthever RCT 2022
1000 mg 200% of trial dose
500 mg
4.7 /5
Medium confidence Strong value signal
800 reviews across 2 platforms (2 sources)
Source diversity: 46%
RedditTrustpilot
PraiseUthever® partnership + published CoAs give it high trust in the community.4.7/5 across ~800 reviews. Highest-rated NMN on Trustpilot.
Last checked: 2026-08-20

Consumer signals

4.7 out of 5 across 800 verified reviews on 2 platforms.

High confidence

Consumer sentiment compiled from 2 public sources (Reddit, Trustpilot).

Reddit

1 thread discussed · positive sentiment

Praise

Uthever® partnership + published CoAs give it high trust in the community.

Compiled from a Reddit r/longevity listing located during manual research; not independently re-verified against the live page at build time.

Trustpilot

800 reviews · 4.7/5 · positive sentiment

Praise4.7/5 across ~800 reviews. Highest-rated NMN on Trustpilot.

Compiled from a Trustpilot listing located during manual research; not independently re-verified against the live page at build time.

These are consumer sentiment signals. They do not measure whether the product actually works. See our evidence section for that.

What others say, with a source hierarchy

We treat external opinion very differently depending on where it comes from. Tier A is our strongest signal. Tier C is background sentiment only. Tier Rejected is what we excluded, listed openly so you can see what we discarded.

These reviews are aggregated from third-party sources, not written by NO1GEVITY. Each entry shows its source, retrieval date, and whether the source has an affiliate or paid relationship. We do not edit reviews to change their meaning. Disclosure policy.

Tier A

Independent deep reviews, lab tests, certificates of analysis

Our strongest external evidence. Long-form independent reviews, physical-product lab work, and third-party certifications.

Healthline
No affiliate relationship Not a paid placement

Healthline's 2026 buyer's guide omits ProHealth Longevity entirely from its recommended list.

Finding: ProHealth Longevity does not appear among Healthline's current top picks (best overall: California Gold Nutrition; best quality/transparency: Double Wood; best value: Nutricost).
How we use it: Used as a neutral, non-affiliate data point noting the product's absence from a reputable comparison guide; not itself a negative or positive review of ProHealth specifically.
Tier B

Registered dietitians and physicians, without affiliate ties

Credentialed commentary from clinicians who disclose no paid relationship. Useful as supporting critique but not a substitute for a clinical outcome trial.

Innerbody
Has affiliate relationship Not a paid placement

Innerbody includes ProHealth in its comparison set but ranks a competing combination product higher overall; treats ProHealth as a credible, higher-priced single-ingredient option.

Finding: Lists ProHealth NMN Pro 1000mg at $115 ($3.83/g); does not select ProHealth as its top overall pick (a different 700mg NMN+NR+BioPerine combination product is named 'best overall').
How we use it: Used as a secondary, disclosed-affiliate comparison point on pricing and category positioning; not used as an endorsement, since Innerbody does not name ProHealth as a top pick and carries an active affiliate discount code (INNERBODY10) for it.
Independent NMN purity testing (22 consumer products, Oct 2021)
No affiliate relationship Not a paid placement

An independent lab test found ProHealth's product accurately labeled, in contrast to most competitors tested.

Finding: ProHealth Longevity NMN Pro 300 tested at 301mg vs. a 300mg label claim (100.3%); one of only three of 21-22 brands tested that contained their labeled NMN amount, while 14 brands reportedly contained less than 1% of the claimed amount.
How we use it: Used as supporting evidence for label accuracy, but flagged with a lower tier because this specific summary of the underlying report is republished on ProHealth's own site rather than sourced directly from the original testing organization's report, whose exact identity/sponsor was not fully confirmed.
Trustpilot (www.prohealth.com)
No affiliate relationship Not a paid placement

A small-sample, below-average rating on the company's main Trustpilot page; a separate ca.trustpilot.com listing for the same domain shows a larger but still modest sample (~62-71 reviews) with a more positive sentiment summary (customers describing 'high-quality, effective' products and 'scientific backing and third-party testing') alongside recurring complaints about customer-service responsiveness and delivery delays.

Finding: 2.5/5 average rating, N=25 reviews on the primary prohealth.com Trustpilot listing.
How we use it: Reported as the primary Trustpilot data point given it is the main company domain, with the sample size (N=25, well below the N>500 threshold for a reliable independent sample) explicitly flagged as a caveat; the ProHealth-hosted on-site review widget (8,345 reviews, 88% 5-star) is not used as independent evidence since it is vendor-controlled.

Community threads and aggregate ratings

Additional public mentions we located, kept separate from the deep independent reviews above.

Reddit r/longevity
positive

Uthever® partnership + published CoAs give it high trust in the community.

Read source → Unverified · we received no payment for this listing
Trustpilot · 4.7
positive

4.7/5 across ~800 reviews. Highest-rated NMN on Trustpilot.

Read source → Unverified · we received no payment for this listing
Layer 3 · Evidence vault

Evidence, claims & regulation

Published evidence, claim checks, regulatory status and what could not be verified.

Evidence, what actually backs this product

Longevity brands rarely test their exact finished product. We separate what's tested from what's inferred.

Strongest evidence tier
Tier 4Ingredient RCT (different dose)
6 studies mapped
Tier 4Ingredient RCT (different dose)
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Yoshino M, Yoshino J, Kayser BD, et al. · 2021 · Science · n=25 · 250 mg/day · 10 weeks
ingredient-levelpeer-reviewed
Muscle insulin sensitivity improved (~25% increase in insulin-stimulated glucose disposal); no improvement in hepatic insulin sensitivity, body composition, or blood lipids.
Flagship human NMN RCT, but at 250 mg/day — one quarter of ProHealth's 1000 mg dose — and in a narrow population (prediabetic postmenopausal women) not representative of the general longevity-supplement buyer. A published critique (Science.org, DOI 10.1126/science.abj1696) flags a baseline hepatic-lipid imbalance between groups as a randomization concern. Ingredient RCT at a different dose than the ProHealth product — Tier 4.
Conflicts: None identified; NIH-funded academic trial (Washington University)
Source →
Tier 4Ingredient RCT (different dose)
Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men
Igarashi M, Nakagawa-Nagahama Y, Miura M, et al. · 2022 · npj Aging · n=42 · 250 mg/day · 6 or 12 weeks
ingredient-levelpeer-reviewed
Significant increases in blood NAD+ and related metabolites; nominally significant improvements in gait speed and left-hand grip strength; no significant change in body composition.
Senior author Toshimasa Yamauchi (University of Tokyo) — this is the likely source of the task brief's 'Yamauchi' reference, though it predates and differs from the 2024 Morifuji sleep/gait trial. Dose (250 mg) is a quarter of ProHealth's 1000 mg claim, and the trial had meaningful attrition. Ingredient RCT at a different dose — Tier 4.
Conflicts: None identified; academic trial (University of Tokyo)
Source →
Tier 4Ingredient RCT (different dose)
Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study
Morifuji M, et al. · 2024 · GeroScience · n=60 · 250 mg/day · 12 weeks
ingredient-levelpeer-reviewed
NMN group showed significantly shorter 4-meter walking time vs. placebo at 12 weeks and improved sleep-quality sub-scores (PSQI daytime dysfunction and global score) vs. placebo.
This is the study most likely intended by the task brief's 'Yamauchi 2024 sleep/gait trial' reference, though the lead author is Morifuji, not Yamauchi; sponsored/announced by Meiji Holdings (https://www.meiji.com/global/news/2024/pdf/240621_01.pdf). Dose (250 mg) is a quarter of ProHealth's 1000 mg product. Ingredient RCT at a different dose — Tier 4.
Conflicts: Sponsored/announced by Meiji Holdings (a NMN/NAD ingredient and consumer-goods company)
Source →
Tier 4Ingredient RCT (different dose)
Safety and efficacy of long-term nicotinamide mononucleotide supplementation on metabolism, sleep, and NAD biosynthesis in healthy, middle-aged Japanese men
Yamaguchi S, Irie J, et al. · 2024 · Endocrine Journal · n=11 · 125 mg twice daily (250 mg/day total) · 8 weeks
ingredient-levelpeer-reviewed
Increased NAD+ in peripheral blood mononuclear cells; modest attenuation of postprandial hyperinsulinemia in the subset who were insulin-oversecretors (n=3); no significant change in sleep quality reported (contrasts with the Morifuji 2024 finding).
Single-arm, open-label design (not placebo-controlled), very small sample (n=11). Included for completeness as a second 2024 Japanese NMN trial that could be confused with the task brief's 'Yamauchi 2024' reference. Dose again a quarter of ProHealth's claim. Ingredient RCT at a different dose, weak design — Tier 4.
Conflicts: None identified
Source →
Tier 4Ingredient RCT (different dose)
Uthever (NMN Supplement): Evaluation of its Safety and Efficacy in an in vivo Model and Human Clinical Trial
Huang H, et al. (Effepharm-affiliated author) · 2022 · Frontiers in Aging · n=66 · 300 mg/day (2 x 150 mg) · 60 days
ingredient-levelpeer-reviewed
NAD+/NADH ratio increased 11.3% by day 30 and 38% by day 60 vs. a 14.3% placebo change; SF-36 quality-of-life score improved 6.5% vs. 3.4% for placebo; HOMA-IR (insulin resistance) remained stable in the NMN group vs. a 30.6% rise in placebo.
This is the single most relevant trial: it is run on the same Uthever raw ingredient ProHealth uses (same manufacturer, Effepharm), but at 300 mg/day — less than one-third of ProHealth's 1000 mg finished-product dose — and not on ProHealth's own capsule. The corresponding author is Effepharm-affiliated, a direct conflict of interest, and this specific 'decreased biological age by 12 years' figure that ProHealth's own marketing attributes to this paper could NOT be independently confirmed in the retrieved abstract/summary of this trial — see claim_check. Ingredient RCT, dose mismatch, company-authored — Tier 4.
Conflicts: Corresponding author affiliated with Effepharm, the manufacturer of the Uthever NMN ingredient tested
Source →
Tier 4Ingredient RCT (different dose)
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial
Yi L, Maier AB, Tao R, et al. · 2022 · GeroScience · n=80 · 300, 600, or 900 mg/day (dose-ranging vs. placebo) · 60 days
ingredient-levelpeer-reviewed
NAD+ levels and physical performance (6-minute walk test) improved dose-dependently, with effects appearing to plateau around 600 mg/day; no safety signal at doses up to 900 mg/day.
This is the closest dose-matched evidence available for ProHealth's 1000 mg product — the 900 mg arm approaches but does not reach the labeled 1000 mg dose, and the trial is again Effepharm-sponsored (same manufacturer as Uthever). No arm tested exactly 1000 mg. Ingredient RCT, close-but-not-matching dose, sponsor conflict — Tier 4.
Conflicts: Effepharm-sponsored dose-ranging trial of its own Uthever NMN ingredient
Source →
Evidence

Research behind this product

The studies that established the trial dose and evidence grade for each active ingredient in this product. Click through to read the original paper.

NMNYi et al. 2023 (GeroScience)
NMNOkabe et al. 2022 (Frontiers in Nutrition)
NMNUthever RCT 2022
NMNNMN meta-analysis 2024 (12 RCTs)
NMNZhang et al. 2026 meta-analysis (Nutrients)

Claim check, vendor claims vs. our reading of the evidence

Not medical advice. We list the strongest claims made by the brand and check each against traceable evidence.

Partial support
“"NMN Pro 1000 capsules provide maximum absorption by focusing delivery into the small intestine's Slc12a8 NMN transporter sites, where NMN absorption is increased over 100 times."”
The underlying science is real but the claim stretches it: Grozio et al. 2019 (Nature Metabolism, https://doi.org/10.1038/s42255-018-0009-4) found the Slc12a8 gene is expressed roughly 100-fold higher in mouse small intestine than in other tissues — a tissue-expression comparison in mice, not a demonstration that ProHealth's specific capsule formulation increases a person's NMN absorption 100x relative to a competitor's product. A 2025 Science Advances paper (Kobayashi et al., https://www.science.org/doi/10.1126/sciadv.adr1538) further found that only a small portion of orally administered NMN or NR is directly absorbed intact from the small intestine, with most first converted to nicotinamide — suggesting the absorption mechanism ProHealth's marketing leans on is still scientifically contested.
Vendor source
Partial support
“"In a published peer reviewed, double blind, placebo controlled clinical trial, 60 days of ProHealth Longevity Uthever NMN: Decreased Biological Age by 12 years; Boosted NAD+ by 38%; Improved quality-of-life measurements by 6.5%."”
The 38% NAD+ increase and 6.5% quality-of-life improvement figures are corroborated by the cited trial (Huang et al. 2022, Frontiers in Aging, https://doi.org/10.3389/fragi.2022.851698). However, that trial used a 300 mg/day dose — less than one-third of the 1000 mg ProHealth actually sells in this product — was run in Pune, India (not on US consumers), and its corresponding author is affiliated with Effepharm, the ingredient manufacturer, a clear conflict of interest. The specific 'decreased biological age by 12 years' figure could not be confirmed in the retrieved summary of this paper; it may be conflated with a different Effepharm-sponsored trial on a separate NMNH product line, which reports a distinct biological-age claim. Buyers should not read this as proof that the exact 1000 mg capsule they are buying was clinically shown to reverse 12 years of aging.
Vendor source
Partial support
“"Every batch of ProHealth Uthever® NMN sold is tested by independent lab in an independent U.S. lab... Certificates of Analysis available on our website."”
A genuine third-party CoA from Micro Quality Labs Inc. (A2LA-accredited) was located for a Uthever NMN batch showing 99.70% purity and heavy metals well within limits. This supports third-party testing occurring at the ingredient level. However, this research pass could not locate a CoA specifically tied to the finished 1000 mg NMN Pro capsule SKU (batch-specific, dated, and matched to the exact product a buyer receives), so full batch-to-bottle traceability for this specific product could not be independently confirmed.
Vendor source

Regulatory status

Rules change often. We record when we last verified each row. See the full regulatory timeline →

What we could not verify

We list this openly. If a claim isn't backed by a source we can trace, we'd rather flag it than repeat it.

  • No CoA specific to the finished 1000 mg NMN Pro capsule SKU (as opposed to the raw Uthever ingredient generally, or other ProHealth pack sizes) was located in this research pass.
  • The specific 'decreased biological age by 12 years' marketing claim, attributed to the Huang et al. 2022 Frontiers in Aging trial, could not be confirmed in the retrieved paper abstract/summary and may be misattributed from a different Effepharm-sponsored trial on a separate product line.
  • Current CEO of ProHealth Longevity could not be reconfirmed; a 2021 trade-press article names Nancy Dayton as CEO, while founder Rich Carson's LinkedIn suggests a Founder/Chairman role since late 2017 rather than day-to-day CEO.
  • ConsumerLab's dedicated ProHealth page (https://www.consumerlab.com/prohealth/) could not be fetched in this pass (timeout); it is unconfirmed whether ConsumerLab has independently tested this specific product.
  • Trustpilot data is inconsistent across regional/domain listings (2.5/5 with N=25 on the main .com domain vs. more positive but similarly small samples on other regional Trustpilot pages) and none reach the N>500 threshold the source-hierarchy guidance treats as a reliable independent sample size.
  • EU sale/novel-food status for NMN, and whether ProHealth ships this product to EU customers under current rules, was not independently confirmed.
Important to know
NMNAbsorption varies wildly by form. Sublingual and liposomal claim better uptake but human head-to-head data is limited.

Editorial notes

Uthever® branded NMN with published CoAs.

Go deeper

Where this sits

Actives inside
NMN
Category
See all in NAD+ booster →
Ranking
See top 10 NMN supplements →
Brand
ProHealth Longevity profile →
Add to compare Visit brand site →
Brand owners

Spot an error?

If you are the manufacturer or brand owner of NMN Pro 1000 and believe any data on this page is incorrect (wrong dose, wrong ingredient, wrong price, missing certification, outdated status), you can request a correction.

We review every request, verify it against primary sources, and publish any accepted change with a dated note. Corrections from brand owners are treated the same as corrections from anyone else: verified before they move.

Request a correction →
Same shelf

Similar products

All NAD+ booster →

The next highest-scoring products in NAD+ booster, same scoring method, same rules.

Renue By Science
NMN Pure Powder (Sublingual)
NAD+ booster
Precursor per serving
NMN 500 mgPowder · 200 servings
Price per serving
$0.32$64.95 · 200 servings
Testing
3rd-party listed · public lab certificate

Status as recorded in the catalog from brand materials; not independently verified by NO1GEVITY.

Score & research context 8.3/10

Editorial score, not proof that this product works. Research-dose calculations are not dosing advice.

100%
of trial dose
$0.32
per research-dose day, not label serving
0Trial dose2×
Catalog price · Confirm current price with renuebyscience.com
DoNotAge
Pure NR
NAD+ booster
Precursor per serving
NR 500 mgPowder · 30 servings
Price per serving
$1.83$55.00 · 30 servings
Testing
3rd-party listed · public lab certificate

Status as recorded in the catalog from brand materials; not independently verified by NO1GEVITY.

Score & research context 8.1/10

Editorial score, not proof that this product works. Research-dose calculations are not dosing advice.

100%
of trial dose
$1.10
per research-dose day, not label serving
0Trial dose2×
Catalog price · Confirm current price with donotage.org
NAD+ booster
Precursor per serving
NMN 250 mgCapsule · 90 servings
Price per serving
$0.56$49.99 · 90 servings
Testing
3rd-party listed · public lab certificate

Status as recorded in the catalog from brand materials; not independently verified by NO1GEVITY.

Score & research context 8.1/10

Editorial score, not proof that this product works. Research-dose calculations are not dosing advice.

100%
of trial dose
$1.11
per research-dose day, not label serving
0Trial dose2×
Catalog price · Confirm current price with nootropicsdepot.com
Same maker

Other products from ProHealth Longevity

Brand profile →
Mitochondrial
Active per serving
Urolithin A 500 mgCapsule · 30 servings
Price per serving
$1.87$55.97 · 30 servings
Testing
3rd-party listed · public lab certificate

Status as recorded in the catalog from brand materials; not independently verified by NO1GEVITY.

Score & research context 8.6/10

Editorial score, not proof that this product works. Research-dose calculations are not dosing advice.

100%
of trial dose
$3.73
per research-dose day, not label serving
0Trial dose2×
Catalog price · Confirm current price with www.prohealth.com
ProHealth Longevity
NMN Pro™ Powder - Uthever® NMN
NAD+ booster
Precursor per serving
NMN 1,000 mgPowder · 100 servings
Price per serving
$0.99$98.95 · 100 servings
Testing
3rd-party listed · public lab certificate

Status as recorded in the catalog from brand materials; not independently verified by NO1GEVITY.

Score & research context 7.9/10

Editorial score, not proof that this product works. Research-dose calculations are not dosing advice.

400%
of trial dose
$0.49
per research-dose day, not label serving
400% · over 2× trial dose0Trial dose2×
Catalog price · Confirm current price with www.prohealth.com
NAD+ booster
Precursor per serving
NR 300 mg+ Betaine (TMG) 100 mg
Price per serving
$0.83$24.95 · 30 servings
Testing
3rd-party listed · public lab certificate

Status as recorded in the catalog from brand materials; not independently verified by NO1GEVITY.

Score & research context 7.5/10

Editorial score, not proof that this product works. Research-dose calculations are not dosing advice.

100%
of trial dose
$0.83
per research-dose day, not label serving
0Trial dose2×
Catalog price · Confirm current price with www.prohealth.com
Mitochondrial
Active per serving
CoQ10 100 mgSoftgel · 60 servings
Price per serving
$0.68$40.99 · 60 servings
Testing
3rd-party listed · public lab certificate

Status as recorded in the catalog from brand materials; not independently verified by NO1GEVITY.

Score & research context 7.3/10

Editorial score, not proof that this product works. Research-dose calculations are not dosing advice.

100%
of trial dose
$1.37
per research-dose day, not label serving
0Trial dose2×
Catalog price · Confirm current price with www.prohealth.com
Adaptogen
Extract per serving
Ashwagandha 600 mgCapsule · 30 servings
Price per serving
$1.10$32.99 · 30 servings
Testing
3rd-party listed · public lab certificate

Status as recorded in the catalog from brand materials; not independently verified by NO1GEVITY.

Score & research context 7.1/10

Editorial score, not proof that this product works. Research-dose calculations are not dosing advice.

100%
of trial dose
$1.10
per research-dose day, not label serving
0Trial dose2×
Catalog price · Confirm current price with www.prohealth.com